相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发,品质稳、品类全,实验不再等!Takara 秋促来袭,提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ¥1200阿拉丁 22万+ 科研级产品现货速发,品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 保质期:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 英文名:
SAR-20347
- 库存:
999
- 供应商:
北京索莱宝科技有限公司
- CAS号:
1450881-55-6
- 规格:
5mg/10mg/25mg/50mg
| 规格: | 5mg | 产品价格: | ¥890.00 |
|---|---|---|---|
| 规格: | 10mg | 产品价格: | ¥1440.00 |
| 规格: | 25mg | 产品价格: | ¥2890.00 |
| 规格: | 50mg | 产品价格: | ¥4490.00 |
| CAS | 1450881-55-6 |
| 英文名称 | SAR-20347 |
| 别名 | CPDD1211;SAR-20347;SAR20347 |
| 分子式 | C21H18ClFN4O4 |
| 分子量 | 444.84 |
| 规格 | 5mg ; 10mg ; 25mg ; 50mg |
| 溶解性 | Soluble in DMSO ≥10mg/mL |
| 纯度 | ≥98% |
| 外观(性状) | Solid |
| 储存条件 | Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| 运输条件 | 冷藏运输 |
| MDL | MFCD28502117 |
| SMILES | C1COCCN1C(=O)C2=CC=C(C=C2)NC3=C(N=C(O3)C4=C(C=CC=C4Cl)F)C(=O)N |
| InChIKey | C1COCCN1C(=O)C2=CC=C(C=C2)NC3=C(N=C(O3)C4=C(C=CC=C4Cl)F)C(=O)N |
| InChI | InChI=1S/C21H18ClFN4O4/c22-14-2-1-3-15(23)16(14)19-26-17(18(24)28)20(31-19)25-13-6- 4-12(5-7-13)21(29)27-8-10-30-11-9-27/h1-7,25H,8-11H2,(H2,24,28) |
| PubChem CID | 71727668 |
| 靶点 | JAK;Tyk2 |
| 通路 | JAK/STAT Signaling |
| 背景说明 | SAR-20347 是 TYK2,JAK1,JAK2 和 JAK3 的抑制剂。 |
| 生物活性 | SAR-20347 is an inhibitor of TYK2, JAK1, JAK2 and JAK3 with IC50s of 0.6, 23, 26 and 41 nM, respectively.[1] |
| In Vitro | When NK-92 cells are stimulated with IL-12, SAR-20347 potently inhibits IL-12-mediated STAT4 phosphorylation, a TYK2-dependent event, with an IC50 of 126 nM. SAR-20347 demonstrates a selectivity of TYK2>JAK1>JAK2>JAK3. Cells without IL-12 in the culture media have no measureable IFN-γ, while cells incubated with IL-12 and SAR-20347 demonstrate dose-dependent inhibition of IFN-γ production. SAR-20347 dose-dependently inhibits the production of secreted embryonic alkaline phosphatase (SEAP) with greatest inhibition occurring with 5 μM of SAR-20347 in these experiments[1]. |
| In Vivo | 60 mg/kg SAR-20347 inhibits the production of IFN-γ in the serum by 91% compare to vehicle-treated animals, demonstrating that SAR-20347 can inhibit TYK2 signaling in vivo. SAR-20347 treatment significantly reduces IL-17 production as measured by average signal intensity, consistent with the gene expression analysis[1]. |
| 细胞实验 | Cells are plated in a 96-well v-bottom plate in starvation medium, incubated with SAR-20347 (0.5% DMSO) for 20 minutes at 37°C, 5% CO2, and stimulated with individual cytokines. P-STAT levels are measured in duplicate using MSD plates following the manufacturers instructions (MSD). The IC50 is determined by subtracting background (no cytokine) and relative to DMSO/cytokine control[1]. |
| 动物实验 | Female 7 to 9 week old C57BL/6 mice are used. Mice are administered vehicle or 50 mg/kg SAR-20347 by oral gavage 30 minutes prior to application of 62.5 mg 5% imiquimod cream or control cream. Another dose of vehicle or 50 mg/kg SAR-20347 is given 5.5 hours following the first dose. This treatment is repeated for 5 days and on day 3 and 4, animals are injected with 100 uL saline to prevent dehydration. Each day, the mice are assessed by the same researcher for redness. On the 6th day, the animals are euthanized and photographs are taken[1]. |
| 激酶实验 | Kinases are prepared in Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/mL BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO) and substrate is added with 1.5 mM CaCl2, 16 μg/mL Calmodulin, and 2 mM MnCl2. Varying concentrations of SAR-20347 in DMSO are added to the kinase reaction along with 10 μM 33P-ATP (activity 0.01 μCi/μL final) for IC50 determination[1]. |
| 数据来源文献 | [1]. Works MG, et al. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis. J Immunol. 2014 Oct 1;193(7):3278-87. |
| 单位 | 瓶 |
| 表格1 | |*|1mg|5mg|10mg|$$|1mM|12.8205mL|64.1026mL|128.2051mL|$$|5mM|2.5641mL|12.8205mL|25.641mL|$$|10mM|1.2821mL|6.4103mL|12.8205mL| |

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Heterologous SERCA1a Ca2+ -ATPase (sarco-endoplasmic reticulum Ca2+ -adenosine triphosphatase isoform 1a) from rabbit was expressed in yeast Saccharomyces cerevisiae as a fusion protein, with a biotin acceptor domain (BAD) linked to the SERCA
三句话读懂一篇 CNS:咖啡竟可降低心律失常风险;转入肥胖基
21 日,北京大学刘颖及陈杰教授团队在 Nature 杂志上发表研究论文 SAR1B senses leucine levels to regulate mTORC1 signalling,该研究发现 SAR1B 是一种保守的亮氨酸感应器,能够调节 mTOR 复合物 1 从而响应细胞内亮氨酸的水平。图 5:来源 Nature6. Nature:肠道炎症影响嗅觉在以往的认知中,嗅觉与大脑、鼻子息息相关。2021 年 7 月 21 日,美国加州诺瓦托巴克老年研究所 Heinrich Jasper 教授
Neuron:北大陈雷研究组报道胞内钙离子对 TRPC3/6 通道调控的机制
活性 CBS3 对 DAG 激活的 TRPC3/6 电流同样产生调节作用。 结构显示在 FSGS 疾病中发现的 TRPC6 GOF 点突变都分布于胞内区亚基间相互作用的界面上,有可能破坏了亚基间的相互作用。为了验证此假说,作者们解析了 GOF 突变体的结构,并通过电生理和热稳定性实验发现 GOF 突变体减弱了抑制性 Ca2+ 结合位点(CBS1)的作用,使胞内区结构变得松散,从而打开了阳离子从胞质内空腔向胞质区流出的孔道。 最后作者们解析了 BTDM 以及 SAR7334 与 TRPC6 结合的高分
技术资料暂无技术资料 索取技术资料











